sacituzumab govitecan breast cancer approval

Keyword Analysis

Keyword	CPC	PCC	Volume	Score	Length of keyword
sacituzumab govitecan breast cancer approval	0.82	0.5	3661	25	44
sacituzumab	1.75	1	1384	39	11
govitecan	1.23	0.9	2261	86	9
breast	1.94	0.6	277	12	6
cancer	0.93	0.4	5248	97	6
approval	1.38	0.9	3726	2	8

Keyword	CPC	PCC	Volume	Score
sacituzumab govitecan breast cancer approval	1.83	0.4	7366	15
sacituzumab govitecan fda approval	0.24	1	6853	38
sacituzumab govitecan bc cancer	2	1	861	20
sacituzumab govitecan-hziy fda approval	0.36	0.6	7168	91
is sacituzumab govitecan chemotherapy	1.68	0.8	7077	20
sacituzumab govitecan ovarian cancer	1.71	0.6	1094	56
sacituzumab govitecan clinical trial	0.4	0.7	2925	69
sacituzumab govitecan fda label	1.41	0.2	4350	15
sacituzumab govitecan lung cancer	0.22	0.1	8701	6
sacituzumab govitecan prescribing information	0.78	1	6637	64
what is sacituzumab govitecan	0.07	0.8	7541	8
sacituzumab govitecan patient information	1.09	0.2	8950	99
sacituzumab govitecan for bladder cancer	1.72	0.3	9385	85
sacituzumab govitecan brand name	0.22	0.2	237	57
sacituzumab govitecan j code	0.25	0.8	3215	10
sacituzumab govitecan fda package insert	2	0.5	3859	93
sacituzumab er positive breast cancer	0.02	0.8	6485	50
sacituzumab govitecan drug class	0.12	0.5	6584	48
sacituzumab govitecan package insert	0.05	0.1	3019	51
is sacituzumab govitecan immunotherapy	0.16	0.9	4968	37
sacituzumab govitecan-hziy	0.61	0.1	4241	39